Over the past two years, the Canadian life sciences industry has endured despite significant global economic uncertainty. Our research provides evidence of a sector that's showing positive signs of maturity. Yet, access to capital remains the missing ingredient that will continue to constrain the sector’s success.
The information gathered and contained within this report builds on findings from previous reports and provides an overview of current industry issues and trends. We trust that you will find the information valuable for contributing to the debate on these issues.